Trial intelligence / Profile preview

Anesthesia in Mitochondrial Disease

NCT02053766Terminated

Sponsor
UTHealth Houston
Start
Jan 2014
Primary completion
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of sevoflurane, propofol injection (veterinary) and dexmedetomidine (3 arms), sponsored by UTHealth Houston. Primary endpoint: Incidence of Adverse Events. Started Jan 2014; status: terminated.

02

Drugs

sevofluranepropofol injection (veterinary)dexmedetomidine

Beyond the preview

Go deeper on NCT02053766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02053766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call